Welcome to CMLAlliance.net | A New World of Support for Ph+ CML

CML Alliance offers a wealth of resources designed to help you and your patients optimize Ph+ CML:

Access monitoring
Educational materials
Patient support materials
Clinical trial information, and more

When patients have Ph+ CML, you want to provide access to the full potential of advanced care for Ph+ CML— and now you can with CML Alliance.

Note: Before prescribing, please read full European Summary of Product Characteristics.

See European Summary of Product Characteristics

[PDF] GLIVEC^® 100 mg film coated tablets

[PDF] GLIVEC^® 400 mg film coated tablets

[PDF] GLIVEC^® 50 mg capsules

[PDF] GLIVEC^® 100 mg capsules

[PDF] TASIGNA^® 150 mg hard capsules

[PDF] TASIGNA^® 200 mg hard capsules

Contact | Site Map | Privacy
Use of this website is subject to our Terms of Use

Disclaimer: This site is intended to provide information to healthcare professionals outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.